BioSpace News Archive

Luminarie Canada Inc. and its development partner 1drop Inc. announced that Health Canada, pursuant to section 5 of the Interim order respecting the importation and sale of medical devices for use in relation to COVID-19, made by the Minister of Health on March 18, 2020, has issued an authorization for importation and sale of 1drop’s novel RT-qPCR “1copy™ COVID-19 qPCR Multi Kit”.

Face masks have become the first line of defense for health care professionals around the globe battling COVID-19. Yet through prolonged use, that same protective equipment may be putting them at further risk.

AbbVie, a research-based global biopharmaceutical company, announced a donation of $35 million to support COVID-19 relief efforts.

BioSyent Inc. announces that its Board of Directors has approved a grant of 129,125 Restricted Share Units “RSUs” to certain directors, officers, management, and employees of the Company pursuant to the Company’s Restricted Share Unit Plan.

ABM Respiratory care, a medical device company focused on developing novel integrated airway clearance and ventilation solutions, announced that it has received 510 clearance to market its innovative cough therapy system.

Zymo Research announced a partnership with Tecan to launch a ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma, and serum.

Daiichi Sankyo granted non-exclusive license to Ultragenyx HeLa manufacturing platform

Amgen K.K. Will Focus on Bringing Amgen’s Full Global Pipeline to Japanese Patients.

Shortages are most common in the hospital setting and are most acute in New York, where the majority of COVID-19 patients are receiving care.

Company highlights significant R&D investments, progress in cell therapy, especially in CAR-T Trials Targeting Gastric Cancer and Other Pipelines